Trial Profile
Post-Marketing Surveillance Orgalutran (Ganirelix).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2022
Price :
$35
*
At a glance
- Drugs Ganirelix (Primary)
- Indications Infertility
- Focus Adverse reactions; Therapeutic Use
- Sponsors Organon
- 03 Mar 2011 New trial record